Header Logo

Connection

Shyam Patel to Humans

This is a "connection" page, showing publications Shyam Patel has written about Humans.
Connection Strength

1.095
  1. Khouri MR, Wang B, Pearson LK, Gillis-Smith AJ, Suzuki S, Hutchinson LM, Bindal P, Ramanathan M, Gerber JM, Cerny J, Patel SA. Characteristics and clinical outcomes of patients with myeloid malignancies and cohesin mutations. Cancer. 2025 Apr 15; 131(8):e35846.
    View in: PubMed
    Score: 0.038
  2. Gerber WK, Xie Y, Patel SA. Expanding the Therapeutic Reach of Chimeric Antigen Receptor T-Cells and Bispecific T-Cell Engagers Across Solid Tumors. JCO Precis Oncol. 2025 Mar; 9:e2400753.
    View in: PubMed
    Score: 0.038
  3. Patel SA, Spiegel JY, Dahiya S. Second Primary Cancer After Chimeric Antigen Receptor-T-Cell Therapy: A Review. JAMA Oncol. 2025 Feb 01; 11(2):174-181.
    View in: PubMed
    Score: 0.037
  4. Patel SA, Weeks LD. Drafting a blueprint for designing successful clinical trials in clonal haematopoiesis. Br J Haematol. 2025 Feb; 206(2):800-802.
    View in: PubMed
    Score: 0.037
  5. Patel SA. Managing the unmanageable: evidence-driven approaches to real-world patient prototypes of TP53-mutant myelodysplastic neoplasms and acute myeloid leukemia. Leukemia. 2024 Dec; 38(12):2544-2551.
    View in: PubMed
    Score: 0.036
  6. Xie Y, Kazakova V, Weeks LD, Gerber JM, Tai J, Zhang TY, Lowsky R, Wu X, Yang C, Patel SA. Effects of donor-engrafted clonal hematopoiesis in allogeneic and autologous stem cell transplantation: a systematic review and meta-analysis. Bone Marrow Transplant. 2024 Nov; 59(11):1585-1593.
    View in: PubMed
    Score: 0.036
  7. Yaniv B, Tanenbaum B, Kazakova V, Patel SA. Translational insights into the genetics and immunobiology of relapsed/refractory follicular lymphoma. Leuk Res. 2024 Jul; 142:107519.
    View in: PubMed
    Score: 0.035
  8. Patel SA, Gerber WK, Zheng R, Khanna S, Hutchinson L, Abel GA, Cerny J, DaSilva BA, Zhang TY, Ramanathan M, Khedr S, Selove W, Woda B, Miron PM, Higgins AW, Gerber JM. Natural history of clonal haematopoiesis seen in real-world haematology settings. Br J Haematol. 2024 May; 204(5):1844-1855.
    View in: PubMed
    Score: 0.035
  9. Patel SA. The heart of VIALE-A: Cardiac complications of hypomethylating agents and venetoclax in acute myeloid leukaemia. Br J Haematol. 2024 Apr; 204(4):1137-1138.
    View in: PubMed
    Score: 0.035
  10. Bello E, Liao H, Patel SA. Clinico-Radio-Pathologic Correlation of Leukostasis in Acute Myeloid Leukemia with FLT3 Mutation. Acta Haematol. 2024; 147(3):388-390.
    View in: PubMed
    Score: 0.034
  11. Patel SA, Bello E, Wilks A, Gerber JM, Sadagopan N, Cerny J. Harnessing autologous immune effector mechanisms in acute myeloid leukemia: 2023 update of trials and tribulations. Leuk Res. 2023 11; 134:107388.
    View in: PubMed
    Score: 0.034
  12. Arun Kumar S, Gao J, Patel SA. The shifting therapeutic paradigm for relapsed/refractory mantle cell lymphoma. Leuk Res. 2023 11; 134:107385.
    View in: PubMed
    Score: 0.034
  13. Gao J, Dahiya S, Patel SA. Challenges and solutions to superior chimeric antigen receptor-T design and deployment for B-cell lymphomas. Br J Haematol. 2023 10; 203(2):161-168.
    View in: PubMed
    Score: 0.033
  14. Patel SA. Precision and strategic targeting of novel mutation-specific vulnerabilities in acute myeloid leukemia: the semi-centennial of 7?+?3. Leuk Lymphoma. 2023 09; 64(9):1503-1513.
    View in: PubMed
    Score: 0.033
  15. Tanenbaum B, Miett T, Patel SA. The emerging therapeutic landscape of relapsed/refractory multiple myeloma. Ann Hematol. 2023 Jan; 102(1):1-11.
    View in: PubMed
    Score: 0.032
  16. Patel SA, Cerny J. TP53-mutant myelodysplastic syndrome and acute myeloid leukemia: the black hole of hematology. Blood Adv. 2022 03 22; 6(6):1917-1918.
    View in: PubMed
    Score: 0.030
  17. Patel SA. Functional genomic approaches in acute myeloid leukemia: Insights into disease models and the therapeutic potential of reprogramming. Cancer Lett. 2022 05 01; 533:215579.
    View in: PubMed
    Score: 0.030
  18. Nuvvula S, Dahiya S, Patel SA. The Novel Therapeutic Landscape for Relapsed/Refractory Diffuse Large B Cell Lymphoma. Clin Lymphoma Myeloma Leuk. 2022 06; 22(6):362-372.
    View in: PubMed
    Score: 0.030
  19. Reid SE, Patel SA. Myocarditis, kidney injury, and hypereosinophilia: FIP1L1-PDGFRA-positive myeloid/lymphoid neoplasm with eosinophilia. Blood. 2021 09 23; 138(12):1086.
    View in: PubMed
    Score: 0.029
  20. Patel SA, Lloyd MR, Cerny J, Shi Q, Simin K, Ediriwickrema A, Hutchinson L, Miron PM, Higgins AW, Ramanathan M, Gerber JM. Clinico-genomic profiling and clonal dynamic modeling of TP53-aberrant myelodysplastic syndrome and acute myeloid leukemia. Leuk Lymphoma. 2021 12; 62(14):3348-3360.
    View in: PubMed
    Score: 0.029
  21. Patel SA, Dalela D, Fan AC, Lloyd MR, Zhang TY. Niche-directed therapy in acute myeloid leukemia: optimization of stem cell competition for niche occupancy. Leuk Lymphoma. 2022 01; 63(1):10-18.
    View in: PubMed
    Score: 0.029
  22. Patel SA, Bledsoe JR, Higgins AW, Hutchinson L, Gerber JM. Rapid and Deep Remission Induced by Blinatumomab for CD19-Positive Chronic Myeloid Leukemia in Lymphoid Blast Phase. JCO Precis Oncol. 2021 07; 5.
    View in: PubMed
    Score: 0.029
  23. Patel SA, Litzow MR, Cerny J. Targeted and cytotoxic therapies as maintenance treatment for non-transplant eligible patients with acute myeloid leukemia. Blood Rev. 2021 11; 50:100863.
    View in: PubMed
    Score: 0.029
  24. Dalela D, Bledsoe JR, Patel SA. Clonal IgH gene rearrangements identify Richter's transformation to diffuse large B cell lymphoma. Ann Hematol. 2021 Dec; 100(12):3075-3077.
    View in: PubMed
    Score: 0.028
  25. Patel SA, Bledsoe JR, Gordon J, Cerny J. Extramedullary Acute Myeloid Leukemia of the Renal Pelvis: Insights into a Visceral Niche. Acta Haematol. 2021; 144(3):297-301.
    View in: PubMed
    Score: 0.027
  26. Patel SA, Gerber JM. A User's Guide to Novel Therapies for Acute Myeloid Leukemia. Clin Lymphoma Myeloma Leuk. 2020 05; 20(5):277-288.
    View in: PubMed
    Score: 0.026
  27. Patel SA. Myelodysplastic Syndrome and Acute Myeloid Leukemia Risk Associated With Solid Tumor Chemotherapy. JAMA Oncol. 2019 03 01; 5(3):303-304.
    View in: PubMed
    Score: 0.025
  28. Patel SA, Longacre TA, Ladabaum U, Lebensohn A, Lin AY, Haraldsdottir S. Tumor Molecular Testing Guides Anti-PD-1 Therapy and Provides Evidence for Pathogenicity of Mismatch Repair Variants. Oncologist. 2018 12; 23(12):1395-1400.
    View in: PubMed
    Score: 0.024
  29. Patel SA. Enasidenib-Induced Differentiation Syndrome in IDH2-Mutant Acute Myeloid Leukemia. JAMA Oncol. 2018 08 01; 4(8):1110-1111.
    View in: PubMed
    Score: 0.024
  30. Patel SA. The inferior vena cava (IVC) syndrome as the initial manifestation of newly diagnosed gastric adenocarcinoma: a case report. J Med Case Rep. 2015 Sep 28; 9:204.
    View in: PubMed
    Score: 0.019
  31. Patel SA, Ramkissoon SH, Bryan M, Pliner LF, Dontu G, Patel PS, Amiri S, Pine SR, Rameshwar P. Delineation of breast cancer cell hierarchy identifies the subset responsible for dormancy. Sci Rep. 2012; 2:906.
    View in: PubMed
    Score: 0.016
  32. Patel SA, Meyer JR, Greco SJ, Corcoran KE, Bryan M, Rameshwar P. Mesenchymal stem cells protect breast cancer cells through regulatory T cells: role of mesenchymal stem cell-derived TGF-beta. J Immunol. 2010 May 15; 184(10):5885-94.
    View in: PubMed
    Score: 0.013
  33. Patel SA, Sherman L, Munoz J, Rameshwar P. Immunological properties of mesenchymal stem cells and clinical implications. Arch Immunol Ther Exp (Warsz). 2008 Jan-Feb; 56(1):1-8.
    View in: PubMed
    Score: 0.011
  34. Ferrer-Diaz AI, Sinha G, Petryna A, Gonzalez-Bermejo R, Kenfack Y, Adetayo O, Patel SA, Hooda-Nehra A, Rameshwar P. Revealing role of epigenetic modifiers and DNA oxidation in cell-autonomous regulation of Cancer stem cells. Cell Commun Signal. 2024 02 12; 22(1):119.
    View in: PubMed
    Score: 0.009
  35. Kennedy A, Patel S, Ramanathan M, Gerber J, Cerny J. Midostaurin for FLT3-mutated AML: a real-world analysis of effectiveness and infection risk at a single center. Ann Hematol. 2024 Mar; 103(3):1031-1033.
    View in: PubMed
    Score: 0.009
  36. Thomas E, Kennedy A, Walsh W, Carpentier M, Adeyinka H, Patel S, Gerber J, Cerny J, Mittal K. Telehealth through the pandemic at a safety net hospital: observations and next steps for cancer care delivery. Front Public Health. 2023; 11:1186350.
    View in: PubMed
    Score: 0.008
  37. Sherman LS, Patel SA, Castillo MD, Unkovic R, Taborga M, Gergues M, Patterson S, Etchegaray JP, Jaloudi M, Hooda-Nehra A, Kra J, Rojas DP, Chang VT, Rameshwar P. NF?B Targeting in Bone Marrow Mesenchymal Stem Cell-Mediated Support of Age-Linked Hematological Malignancies. Stem Cell Rev Rep. 2021 12; 17(6):2178-2192.
    View in: PubMed
    Score: 0.007
  38. Sandiford OA, Donnelly RJ, El-Far MH, Burgmeyer LM, Sinha G, Pamarthi SH, Sherman LS, Ferrer AI, DeVore DE, Patel SA, Naaldijk Y, Alonso S, Barak P, Bryan M, Ponzio NM, Narayanan R, Etchegaray JP, Kumar R, Rameshwar P. Mesenchymal Stem Cell-Secreted Extracellular Vesicles Instruct Stepwise Dedifferentiation of Breast Cancer Cells into Dormancy at the Bone Marrow Perivascular Region. Cancer Res. 2021 03 15; 81(6):1567-1582.
    View in: PubMed
    Score: 0.007
  39. Azizi A, Ediriwickrema A, Dutta R, Patel SA, Shomali W, Medeiros B, Iberri D, Gotlib J, Mannis G, Greenberg P, Majeti R, Zhang T. Venetoclax and hypomethylating agent therapy in high risk myelodysplastic syndromes: a retrospective evaluation of a real-world experience. Leuk Lymphoma. 2020 11; 61(11):2700-2707.
    View in: PubMed
    Score: 0.007
  40. Khan S, Choi J, Patel SA, Spain DA. Altered mental status and hypercalcemia with a splenic mass. J Trauma Acute Care Surg. 2020 03; 88(3):e114-e115.
    View in: PubMed
    Score: 0.007
  41. Gao B, Dwivedi S, Patel SA, Nwizu C, Cruz AI. Operative Versus Nonoperative Management of Displaced Midshaft Clavicle Fractures in Pediatric and Adolescent Patients: A Systematic Review and Meta-Analysis. J Orthop Trauma. 2019 Nov; 33(11):e439-e446.
    View in: PubMed
    Score: 0.006
  42. Nahas GR, Murthy RG, Patel SA, Ganta T, Greco SJ, Rameshwar P. The RNA-binding protein Musashi 1 stabilizes the oncotachykinin 1 mRNA in breast cancer cells to promote cell growth. FASEB J. 2016 Jan; 30(1):149-59.
    View in: PubMed
    Score: 0.005
  43. Guiro K, Patel SA, Greco SJ, Rameshwar P, Arinzeh TL. Investigating breast cancer cell behavior using tissue engineering scaffolds. PLoS One. 2015; 10(3):e0118724.
    View in: PubMed
    Score: 0.005
  44. Rasouli J, Patel SA, Skovrlj B, Gologorsky Y, Mascitelli J, Petersen B, Caridi J. Primary extranodal marginal zone lymphoma involving the skull. J Clin Neurosci. 2014 Feb; 21(2):351-3.
    View in: PubMed
    Score: 0.004
  45. Helmy KY, Patel SA, Nahas GR, Rameshwar P. Cancer immunotherapy: accomplishments to date and future promise. Ther Deliv. 2013 Oct; 4(10):1307-20.
    View in: PubMed
    Score: 0.004
  46. Park JM, Munoz JL, Won BW, Bliss SA, Greco SJ, Patel SA, Kandouz M, Rameshwar P. Exogenous CXCL12 activates protein kinase C to phosphorylate connexin 43 for gap junctional intercellular communication among confluent breast cancer cells. Cancer Lett. 2013 Apr 30; 331(1):84-91.
    View in: PubMed
    Score: 0.004
  47. Navarro P, Ramkissoon SH, Shah S, Park JM, Murthy RG, Patel SA, Greco SJ, Rameshwar P. An indirect role for oncomir-519b in the expression of truncated neurokinin-1 in breast cancer cells. Exp Cell Res. 2012 Dec 10; 318(20):2604-15.
    View in: PubMed
    Score: 0.004
  48. Munoz JL, Greco SJ, Patel SA, Sherman LS, Bhatt S, Bhatt RS, Shrensel JA, Guan YZ, Xie G, Ye JH, Rameshwar P, Siegel A. Feline bone marrow-derived mesenchymal stromal cells (MSCs) show similar phenotype and functions with regards to neuronal differentiation as human MSCs. Differentiation. 2012 Sep; 84(2):214-22.
    View in: PubMed
    Score: 0.004
  49. Greco SJ, Patel SA, Rameshwar P. A reporter assay to detect transfer and targeting of miRNAs in stem cell-breast cancer co-cultures. Methods Mol Biol. 2012; 879:195-201.
    View in: PubMed
    Score: 0.004
  50. Nahas GR, Patel SA, Bliss SA, Rameshwar P. Can breast cancer stem cells evade the immune system? Curr Med Chem. 2012; 19(35):6036-49.
    View in: PubMed
    Score: 0.004
  51. Kapoor S, Patel SA, Kartan S, Axelrod D, Capitle E, Rameshwar P. Tolerance-like mediated suppression by mesenchymal stem cells in patients with dust mite allergy-induced asthma. J Allergy Clin Immunol. 2012 Apr; 129(4):1094-101.
    View in: PubMed
    Score: 0.004
  52. Sherman LS, Munoz J, Patel SA, Dave MA, Paige I, Rameshwar P. Moving from the laboratory bench to patients' bedside: considerations for effective therapy with stem cells. Clin Transl Sci. 2011 Oct; 4(5):380-6.
    View in: PubMed
    Score: 0.004
  53. Patel N, Klassert TE, Greco SJ, Patel SA, Munoz JL, Reddy BY, Bryan M, Campbell N, Kokorina N, Sabaawy HE, Rameshwar P. Developmental regulation of TAC1 in peptidergic-induced human mesenchymal stem cells: implication for spinal cord injury in zebrafish. Stem Cells Dev. 2012 Jan 20; 21(2):308-20.
    View in: PubMed
    Score: 0.004
  54. Lim PK, Bliss SA, Patel SA, Taborga M, Dave MA, Gregory LA, Greco SJ, Bryan M, Patel PS, Rameshwar P. Gap junction-mediated import of microRNA from bone marrow stromal cells can elicit cell cycle quiescence in breast cancer cells. Cancer Res. 2011 Mar 01; 71(5):1550-60.
    View in: PubMed
    Score: 0.004
  55. Helmy KY, Patel SA, Silverio K, Pliner L, Rameshwar P. Stem cells and regenerative medicine: accomplishments to date and future promise. Ther Deliv. 2010 Nov; 1(5):693-705.
    View in: PubMed
    Score: 0.003
  56. Heinrich AC, Patel SA, Reddy BY, Milton R, Rameshwar P. Multi- and inter-disciplinary science in personalized delivery of stem cells for tissue repair. Curr Stem Cell Res Ther. 2009 Jan; 4(1):16-22.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.